World Wide Web

, Volume 18, Issue 4, pp 1163–1175 | Cite as

Automatic summarization of risk factors preceding disease progression an insight-driven healthcare service case study on using medical records of diabetic patients

  • Pei-Yun S. Hsueh
  • Xin Xin Zhu
  • Mark J. H. Hsiao
  • Selina Y. F. Lee
  • Vincent Deng
  • Sreeram Ramakrishnan


In this study we consider the problem of how to derive insight from medical records to define and improve healthcare services. As noted in many guidelines, risk factors are important to determining the care plan of chronic disease patients, e.g., pre-diabetic or diabetic patients who have started on hemoglobin A1c (HbA1c) control medications. Whereas the traditional management of chronic disease relies on a predetermined set of risk factors, without regard to patient-specific status, literature and recently released guidelines have suggested a less-prescriptive approach that allows flexibility in disease management plans to account for patient-centric information shown in medical records. However, methods of systematically summarizing medical records into risk factors have not been evaluated to support such a patient-centric focus in healthcare services. In this study, we evaluated automatic methods that can identify risk factors important for classifying Diabetic patients at risk of worsen disease progression. In particular, we used the prescription of cardiovascular disease (CVD) medication as the indicator of CVD co-morbidity development in Diabetic patients. We evaluated the summaries obtained with different sources of health information on the risk stratification task and examined the quality of the generated summaries using various proposed intrinsic metrics. In addition, we evaluated to what extent we can reduce the whole medical records into a small set of risk factors. The evaluation illustrates the potential of risk factor summarization and hints on how it can be used to enable practitioners in care planning and to support complex follow-up services at both the point of care and the extended care settings.


Healthcare service design Case study Disease management Data-driven analytics Medical record summarization 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Adibhatla, R.M., Hatcher, J.F.: Altered Lipid Metabolism in Brain Injury and Disorders. Subcell. Biochem. 49, 241–68 (2008)CrossRefGoogle Scholar
  2. 2.
    Brindle, P.M., Beswick, A.D., Fahey, T., Ebrahim, S.B.: The accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: A systematic review. Heart 92(12), 1752–9 (2006)CrossRefGoogle Scholar
  3. 3.
    Brindle, P., Emberson, J., Lampe, F., Walker, M., Whincup, P., Fahey, T., Ebrahim, S.: Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort study. BMJ 327(7426), 1267 (2003)CrossRefGoogle Scholar
  4. 4.
    Brown, A.F., et al.: Race, Ethnicity, Socioeconomic Position and Quality of Care for Adults with Diabetes Enrolled in Managed Care: the Translating Research Into Action for Diabetes (TRIAD) study. Diabetes Care 28(12), 2864–2870 (2005)CrossRefGoogle Scholar
  5. 5.
    Cairncross, J.G., Ueki, K., Zlatescu, M.C., Lisle, D.K., Finkelstein, D.M., Hammond, R.R., Silver, J.S., Stark, P.C., Macdonald, D.R., Ino, Y., Ramsay, D.A., Louis, D.N.: Specific Genetic Predictors of Chemotherapeutic Response and Survival in Patients with Anaplastic Oligodendrogliomas. J. Natl. Cancer Inst. 90(19), 1473–9 (1998)CrossRefGoogle Scholar
  6. 6.
    Carr VL, Sangiorgi D, Büscher M, Junginger S, Cooper R. Integrating evidence-based design and experience-based approaches in healthcare service design. HERD. 2011 Summer; 4 (4):12–33Google Scholar
  7. 7.
    Chobanian, A.V., et al.: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JAMA 289(19), 2560–71 (2003)CrossRefGoogle Scholar
  8. 8.
    Concaro S, Sacchi L, Cerra C, Stefanelli M. Temporal Data Mining for the Assessment of the Costs Related to Diabetes Mellitus Pharmacological Treatment. Proc. AMIA 2009 Symposium Proceedings 2009; 119–123.Google Scholar
  9. 9.
    D’Agostino Sr., R.B., Vasan, R.S., Pencina, M.J., Wolf, P.A., Cobain, M., Massaro, J.M., Kannel, W.B.: General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 117(6), 743–53 (2008)CrossRefGoogle Scholar
  10. 10.
    de Ruijter, W., Westendorp, R.G.J., Assendelft, W.J.J., den Elzen, W.P.J., de Craen, A.J.M., le Cessie, S., Gussekloo, J.: Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study. BMJ 338(7688), a3083 (2008)Google Scholar
  11. 11.
    Genest, J., Libby, P.: Lipoprotein disorders and cardiovascular disease. In: Bonow, R.O., Mann, D.L., Zipes, D.P., Libby, P. (eds.) Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine, 9th edn. Elsevier, Philadelphia (2011). chap 47Google Scholar
  12. 12.
    Henry N. Ginsberg. the ACCORD (Action to Control Cardiovascular Risk in Diabetes) Lipid Trial: What we learn from subgroup analyses. Diabetes Care May 2011; 34 (2): 107–108.Google Scholar
  13. 13.
    Inzucchi, S.E., Bergenstal, R.M., Buse, J.B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A.L., Tsapas, A., Wender, R., Matthews, D.R.: Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 35(6), 1364–79 (2012)CrossRefGoogle Scholar
  14. 14.
    Johansson, B.B.: Hypertension Mechanisms Causing Stroke. Clin. Exp. Pharmacol. Physiol. 26, 563–565 (1999)CrossRefGoogle Scholar
  15. 15.
    Klausen, K., Borch-Johnsen, K., Feldt-Rasmussen, B., Jensen, G., Clausen, P., Scharling, H., Appleyard, M., Jensen, J.S.: Very Low Levels of Microalbuminuria Are Associated With Increased Risk of Coronary Heart Disease and Death Independently of Renal Function, Hypertension, and Diabetes. Circulation 110(1), 32–5 (2004)CrossRefGoogle Scholar
  16. 16.
    Klein, T.E., Altman, R.B., et al.: Estimation of the warfarin dose with clinical and pharmacogenetic data. N. Engl. J. Med. 360, 753–764 (2009)CrossRefGoogle Scholar
  17. 17.
    Lindstrom J. and Tuomilehto J. The Diabetes Risk Score: A practical tool to predict type 2 diabetes risk Diabetes Care 2003; 26:3: 725–731.Google Scholar
  18. 18.
    Liu, J., Hong, Y., D’Agostino Sr., R.B., Wu, Z., Wang, W., Sun, J., Wilson, P.W., Kannel, W.B., Zhao, D.: Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study. JAMA 291(21), 2591–9 (2004)CrossRefGoogle Scholar
  19. 19.
    Owens, D.K.: Improving practice guidelines with Patient-Specific Recommendations. Ann. Intern. Med. 154(9), 638–9 (2011)MathSciNetCrossRefGoogle Scholar
  20. 20.
    Park, J., Edington, D.W.: A Sequential Neural Network Model for Diabetes Prediction. Artif. Intell. Med. 23, 277–293 (2001)CrossRefGoogle Scholar
  21. 21.
    The Look AHEAD Research Group: Effect of the Look AHEAD Study Intervention on Medication Use and Related Cost to Treat Cardiovascular Disease Risk Factors in Individuals With Type 2 Diabetes. Diabetes Care 33(6), 1153–1158 (2010)CrossRefGoogle Scholar
  22. 22.
    Victor, R.G.: Arterial hypertension. In: Goldman, L., Schafer, A.I. (eds.) Cecil Medicine, 24th edn. Elsevier, Philadelphia (2011). chap 67Google Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Pei-Yun S. Hsueh
    • 1
  • Xin Xin Zhu
    • 1
  • Mark J. H. Hsiao
    • 2
  • Selina Y. F. Lee
    • 2
  • Vincent Deng
    • 2
  • Sreeram Ramakrishnan
    • 1
  1. 1.IBM T.J. Watson Research CenterYorktown HeightsUSA
  2. 2.IBM Research CollaboratoryTaipeiTaiwan

Personalised recommendations